When and How to Adjust Non-Pharmacological Interventions Concurrent with Booster Vaccinations Against COVID-19 — Guangdong, China, 2022

INTRODUCTION: With the large-scale roll-out of the coronavirus disease 2019 (COVID-19) booster vaccination effort (a vaccine dose given 6 months after completing primary vaccination) in China, we explore when and how China could lift non-pharmacological interventions (NPIs) against COVID-19 in 2022....

Descripción completa

Detalles Bibliográficos
Autores principales: He, Guanhao, Zeng, Fangfang, Xiao, Jianpeng, Zhao, Jianguo, Liu, Tao, Hu, Jianxiong, Zhang, Sicong, Lin, Ziqiang, Zhu, Huaiping, Liu, Dan, Kang, Min, Zhong, Haojie, Li, Yan, Sun, Limei, Yang, Yuwei, Li, Zhixing, Rong, Zuhua, Zeng, Weilin, Li, Xing, Zhu, Zhihua, Liang, Xiaofeng, Ma, Wenjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022
Materias:
Methods and Applications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930405/
https://www.ncbi.nlm.nih.gov/pubmed/35356641
http://dx.doi.org/10.46234/ccdcw2022.048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930405/
https://www.ncbi.nlm.nih.gov/pubmed/35356641
http://dx.doi.org/10.46234/ccdcw2022.048

Ejemplares similares